Quantum-Si says Proteus now recognises every natural amino acid, ahead of its own target
The US protein-sequencing firm says its instrument platform can now identify all 20 natural building blocks of proteins in individual molecules, but gave no figures or launch date.
18 Nov 2026 · Quantum-Si Inc QSI · Company news
Quantum-Si Inc said on 18 November 2026 that its Proteus development programme can now identify each of the 20 naturally occurring amino acids in individual molecules. The company had set itself the end of 2026 for this goal, so it has arrived somewhat early by its own measure.
Subscribe to keep reading
$4.99 / month
- Every article, analysis and opinion piece on CompePharma and VigiEye
- One subscription for both sites, cancel any time
or
Company's press release (SEC filing): Quantum-Si Inc ↗
Written by CompePharma's editorial system from the company's filing; claims are the company's. AI-assisted; check the source before acting. Not investment advice.
More IndustryAll →
Industry
iMDx Pauses FDA De Novo Review of GraftAssureDx Kidney Rejection Test, Plans January Response
16 Nov 2026 · Insight Molecular Diagnostics Inc. IMDX · Company news
Industry
Cumberland to file ifetroban NDA for Duchenne cardiomyopathy under FDA rolling submission
16 Nov 2026 · Cumberland Pharmaceuticals Inc CPIX · Company news
Industry
FDA sets 25 March 2027 goal date for Unicycive's resubmitted oxylanthanum carbonate application
16 Nov 2026 · Unicycive Therapeutics, Inc. UNCY · Company news
Industry
FDA grants orphan drug designation to Noema's basimglurant for trigeminal neuralgia
16 Nov 2026 · Noema Pharma AG · Company news
Industry
Sono Group updates share counts ahead of 11 December redomiciliation vote
16 Nov 2026 · Sono Group N.V. SSM · Company news
Industry
FDA issues complete response letter for Summit's ivonescimab in EGFR-mutant NSCLC
16 Nov 2026 · Summit Therapeutics Inc. SMMT · Company news